Skip to main content
. 2016 Feb 19;7(13):15828–15839. doi: 10.18632/oncotarget.7489

Figure 3. Association of RUNX1 expression with the prognostic significance in ELN genetic groups.

Figure 3

(A) OS and (B) EFS of CN-AML patients in the ELN favorable genetic group. (C) OS and (D) EFS of CN-AML patients in the ELN intermediate-I genetic group.